Most Cited Articles

Open access

ISSN: 2542-5684
CN: 44-1725/R
p-ISSN: 2096-2878

Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis

Share article

Endoplasmic reticulum stress and liver diseases

Share article

The acidic pathway of bile acid synthesis: Not just an alternative pathway

Share article

Bile acid receptors and gastrointestinal functions

Share article

Mitochondrial damage and biogenesis in acetaminophen-induced liver injury

Share article

The role of gut microbiota in liver disease development and treatment

Share article

Pyrrolizidine alkaloids: An update on their metabolism and hepatotoxicity mechanism

Share article

Vitamins and non-alcoholic fatty liver disease: A molecular insight

Share article

Dysregulation of glutathione synthesis in liver disease

Share article

Structural perspectives of the CYP3A family and their small molecule modulators in drug metabolism

Share article

Intestinal barrier function and metabolic/liver diseases

Share article

Microbiome dysbiosis and alcoholic liver disease

Share article

Dietary fatty acids and bioactive fatty acid metabolites in alcoholic liver disease

Share article

Inhibition of mitochondrial fatty acid oxidation in drug-induced hepatic steatosis

Share article

Functional roles of CCL5/RANTES in liver disease

Share article

Bile acid receptors and signaling crosstalk in the liver, gut and brain

Share article

Metformin alleviates cholestasis-associated nephropathy through regulating oxidative stress and mitochondrial function

Share article

Biliary endoscopy in the management of primary sclerosing cholangitis and its complications

Share article

Chlorpromazine protects against acetaminophen-induced liver injury in mice by modulating autophagy and c-Jun N-terminal kinase activation

Share article

Mitigation of cholestasis-associated hepatic and renal injury by edaravone treatment: Evaluation of its effects on oxidative stress and mitochondrial function

Share article

Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease

Share article

MiR-22 as a metabolic silencer and liver tumor suppressor

Share article

Nuclear receptors and non-alcoholic fatty liver disease: An update

Share article

Stay Informed

Register your interest and receive email alerts tailored to your needs. Sign up below.